Emerald Health Plans for 1,000,000 Square Feet of Cultivation Space by End of 2018
Ryan Allway
December 6th, 2017
Exclusive, News, Top News
Canada’s cannabis industry is expected to reach $22.6 billion over the coming years, according to Deloitte, following the legalization of adult-use cannabis next year. Many licensed producers have responded by dramatically increasing their production capacity, but Emerald Health Therapeutics Inc. (TSX-V: EMH) (OTCQX: EMHTF) stands out with plans to have more than one million square feet of cultivation space operational by the end of next year.
In this article, we will take a closer look at the company’s recent preliminary approvals from Health Canada, its Pure Sunfarms partnership, and what sets it apart from other licensed producers.
New Facility Approved
Emerald Health recently announced that the first 75,000 square foot of its Metro Vancouver greenhouse facility has met the requirements of a preliminary paper-based review of Health Canada’s Office of Medical Cannabis (OMC), which puts it on track to move into the cultivation phase next year. The OMC confirmed satisfactory provision of information regarding the security plan, record keeping and tracking systems, QA reports, and security clearances among key personnel.
“As with Health Canada’s fast paper-based review of our Pure Sunfarms facility, we appreciate their quick preliminary review of our licensed producer application for Emerald Health’s fourth site,” said CEO Chris Wagner in a recent press release. “With significant, secure supply from our large-scale Pure Sunfarms partnership and Emerald facilities, and our value-added product development plans, we intend to be well positioned for growth in the adult use market.”
The new facility will consist of two 75,000 square foot modules of hybrid indoor-greenhouse space expected to be completed by summer 2018. By the end of 2018, management anticipates expanding the facility to a total of over 500,000 square feet of cultivation space with corporate offices and additional space for extraction of oils and processes to create other value-added products. Situated on a 32-acre site, this facility can be expanded to one million square feet.
Pure Sunfarms Partnership
Emerald Health partnered with Village Farms (TSX-V: VFF) earlier this year to retrofit its existing 25-acre 1.1 million square foot greenhouse being used to grow tomatoes to cultivate cannabis, with the goal to be a large-scale, low-cost producer. In September, the partnership, called Pure Sunfarms, submitted an application to Health Canada to become a cannabis Licensed Producer. Emerald Health also optioned an additional 3.7 million square feet of existing greenhouse space in the same Delta complex.
“Partnering with Village Farms, one of North America’s largest and most efficient greenhouse growers, on this tremendous opportunity, is a very exciting development for Emerald,” said Executive Chairman Avtar Dhillon, MD, in a press release at the time. “Village Farms is a global leader in greenhouse growing and, importantly, an expert in the complex matter of safety for agricultural consumables.”
Management anticipates that the first 250,000 square foot conversion of the 1.1 million square foot greenhouse will be completed in February, with a first harvest ready prior to adult-use legalization, anticipated in July of 2018. The second 250,000 square foot expansion is targeted for completion in the third quarter of 2018, which would bring the total cultivation space up to 500,000 square feet. Since it’s a 50/50 partnership, Emerald Health would essentially own roughly 250,000 square feet of production by the end of next year.
Following completion of the whole 1.1 million square foot retrofit, Pure Sunfarms has an option to similarly develop an additional 3.7 million square feet of greenhouse production area. Combined with the 1 million square feet from the Metro Vancouver campus, this puts Emerald Health at 5.8 million square feet of potential production area and among the very largest licensed producers, in terms of production potential, both in Canada and internationally.
Looking Ahead
Emerald Health Therapeutics Inc. (TSX-V: EMH) (OTCQX: EMHTF) represents a compelling investment opportunity in Canada’s burgeoning cannabis industry. With more than 750,000 square feet of cultivation space expected by the end of next year, the company will be among the largest producers of cannabis in the world. Meanwhile, its focus on product innovation through product development and clinical research will help differentiate it as the industry becomes more commoditized.
For more information, visit the company’s website or investor presentation.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.
Quadron Cannatech Corporation is a Vancouver based automated extraction and processing solutions company.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
